- Home
- SXTP vs SHPH Comparison
SXTP vs SHPH Comparison
Compare SXTP & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- SHPH
- Stock Information
- Founded
- SXTP 2010
- SHPH 2012
- Country
- SXTP United States
- SHPH United States
- Employees
- SXTP N/A
- SHPH N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- SHPH Health Care
- Exchange
- SXTP Nasdaq
- SHPH Nasdaq
- Market Cap
- SXTP 3.0M
- SHPH 3.3M
- IPO Year
- SXTP 2023
- SHPH 2022
- Fundamental
- Price
- SXTP $1.04
- SHPH $1.21
- Analyst Decision
- SXTP Buy
- SHPH
- Analyst Count
- SXTP 2
- SHPH 0
- Target Price
- SXTP $28.80
- SHPH N/A
- AVG Volume (30 Days)
- SXTP 87.5K
- SHPH 34.8K
- Earning Date
- SXTP 11-18-2024
- SHPH 11-12-2024
- Dividend Yield
- SXTP N/A
- SHPH N/A
- EPS Growth
- SXTP N/A
- SHPH N/A
- EPS
- SXTP N/A
- SHPH N/A
- Revenue
- SXTP $441,255.00
- SHPH N/A
- Revenue This Year
- SXTP $267.05
- SHPH N/A
- Revenue Next Year
- SXTP $181.82
- SHPH N/A
- P/E Ratio
- SXTP N/A
- SHPH N/A
- Revenue Growth
- SXTP 12.07
- SHPH N/A
- 52 Week Low
- SXTP $0.92
- SHPH $1.03
- 52 Week High
- SXTP $18.36
- SHPH $4.96
- Technical
- Relative Strength Index (RSI)
- SXTP 39.03
- SHPH 41.36
- Support Level
- SXTP $0.92
- SHPH $1.11
- Resistance Level
- SXTP $1.38
- SHPH $1.25
- Average True Range (ATR)
- SXTP 0.11
- SHPH 0.10
- MACD
- SXTP 0.01
- SHPH 0.04
- Stochastic Oscillator
- SXTP 26.72
- SHPH 52.94
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.